GlassScriptPhysician profile
Deborah D Welsh
NPI 1851631410
$7,345.08
in general payments reported to CMS, 2019-2025
41 companies · $631 in 2025
The $631 reported for 2025 was more than what 77% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,463 · 2022: $1,533 · 2023: $1,928 · 2024: $790 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,348.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,390.94 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $640.34 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $380.69 | 2021-2024 | Nuplazid |
| Csl Behring | $374.09 | 2021-2025 | Hizentra |
| Lundbeck LLC | $303.38 | 2021-2025 | Vyepti |
| Biogen, INC. | $290.99 | 2021-2023 | Vumerity |
| Lilly USA, LLC | $285.93 | 2021-2025 | Amyvid, Kisunla, Emgality |
| Neurelis, INC. | $275.08 | 2021-2023 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $266.93 | 2021-2025 | Austedo Xr, Austedo, Austedo Xr |
| Avanir Pharmaceuticals, INC. | $257.85 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $241.92 | 2022-2024 | Ultomiris, Soliris |
| Neurocrine Biosciences, INC. | $208.68 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $200.27 | 2021 | |
| Emd Serono, INC. | $195.80 | 2021-2025 | Mavenclad |
| Jazz Pharmaceuticals INC. | $187.93 | 2021-2023 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Welsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.